Multiple lines of evidence have implicated brain-derived neurotrophic factor (BDNF) in
treatment-resistant depression (TRD). The aim of this synthesis was to determine the impact …

Currently, the diagnosis of major depressive disorder (MDD) mainly relies on clinical
examination and subjective evaluation of depressive symptoms. There is no non-invasive …

Objective To investigate the effects of repetitive transcranial magnetic stimulation (rTMS) on
serum levels of brain-derived neurotrophic factor (BDNF), interleukin (IL)-1β, and tumor …

Objective We performed a systematic review and meta-analysis to estimate brain-derived
neurotrophic factor (BDNF) level in patients with major depressive disorder (MDD) after …

Emerging data suggest that Electro-Convulsive Treatment (ECT) may reduce depressive
symptoms by increasing the expression of Brain-Derived Neurotrophic Factor (BDNF). Yet …

Abstract Treatment-resistant depression (TRD) is a challenging issue to address. Repetitive
transcranial magnetic stimulation (rTMS) is commonly used but shows varying efficacy …

Objective There is a lack of established biological, psychological, social, and digital markers
for the prediction, identification, and stratification of patients with major depressive disorder …

Introduction Since its discovery several decades ago, nerve growth factor (NGF) has been
found to play roles in different areas, such as neurology, endocrinology, and immunology …

The current Review article provides a narrative review about the neurobiological
underpinnings and treatment of treatment resistant late-life depression (TRLLD). The …

Introduction The induction of brain-derived neurotrophic factor (BDNF) release and
subsequent restoration of neuroplastic homeostasis may underlie the effects of …